BANK OF MONTREAL /CAN/ - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$192,000
-66.6%
56,680
-43.7%
0.00%
Q1 2022$574,000
-62.0%
100,600
-38.0%
0.00%
-100.0%
Q4 2021$1,511,000
-19.5%
162,130
-1.2%
0.00%0.0%
Q3 2021$1,878,000
-66.2%
164,170
-53.1%
0.00%
-66.7%
Q2 2021$5,560,000
+10390.6%
350,109
+11252.4%
0.00%
Q1 2021$53,000
-80.7%
3,084
-78.2%
0.00%
Q4 2020$274,000
+214.9%
14,178
+137.4%
0.00%
Q3 2020$87,000
-38.7%
5,971
-34.4%
0.00%
Q2 2020$142,000
+491.7%
9,100
+346.7%
0.00%
Q1 2020$24,000
-93.1%
2,037
-86.3%
0.00%
Q4 2019$347,000
-38.7%
14,821
-51.5%
0.00%
Q3 2019$566,000
+269.9%
30,579
+272.9%
0.00%
Q2 2019$153,000
+159.3%
8,200
+243.8%
0.00%
Q1 2019$59,000
-95.5%
2,385
-95.3%
0.00%
-100.0%
Q4 2018$1,323,000
+800.0%
51,032
+997.9%
0.00%
Q3 2018$147,000
-27.6%
4,648
-11.1%
0.00%
Q2 2018$203,000
+56.2%
5,228
+11.2%
0.00%
Q1 2018$130,000
+62.5%
4,701
+5.6%
0.00%
Q4 2017$80,000
+8.1%
4,451
-3.2%
0.00%
Q3 2017$74,000
+37.0%
4,600
+18.1%
0.00%
Q2 2017$54,000
+25.6%
3,896
+34.5%
0.00%
Q1 2017$43,000
-73.5%
2,896
-72.3%
0.00%
Q4 2016$162,000
-18.2%
10,462
-8.9%
0.00%
Q3 2016$198,000
+2728.6%
11,482
+2707.3%
0.00%
Q2 2016$7,000
-12.5%
4090.0%0.00%
Q1 2016$8,000
-99.7%
409
-99.6%
0.00%
-100.0%
Q4 2015$3,010,000112,7200.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders